Mark W. Orme
68Patents
15h-index
52Co-inventors
87Inventor score
Filing activity: Jan 2, 1992 → May 24, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6649631B1 | Compositions and methods for treating bone deficit conditions | Human Necessities | 112 | Expired |
| US5919808A | Compositions and methods for treating bone deficit conditions | Human Necessities | 109 | Expired |
| US5965573A | Compositions and methods for treating bone deficit conditions | Human Necessities | 106 | Expired |
| US5922753A | Methods for treating bone deficit conditions with benzothiazole | Human Necessities | 96 | Expired |
| US6153631A | Compositions and methods for treating bone deficit conditions | Human Necessities | 90 | Expired |
| US5948776A | Compositions and methods for treating bone deficit conditions | Human Necessities | 85 | Expired |
| US5990169A | Compositions and methods for treating bone deficit conditions | Human Necessities | 84 | Expired |
| US6342514B1 | Compositions and methods for treating bone deficit conditions | Human Necessities | 83 | Expired |
| US6251901A | Compositions and methods for treating bone deficit conditions | Human Necessities | 81 | Expired |
| US5994358A | Compositions and methods for treating bone deficit conditions | Human Necessities | 81 | Expired |
| US7982071B2 | Alkoxy compounds for disease treatment | Chemistry; Metallurgy | 48 | Active |
| US8076516B2 | Amine derivative compounds for treating ophthalmic diseases and disorders | Chemistry; Metallurgy | 28 | Active |
| US5731326A | PDGF antagonists II | Human Necessities | 20 | Expired |
| US6872721B2 | Derivatives of 2,3,6,7,12,12a-hexahydropyrazino-[1′,2′:1,6]pyrido[3,4b]-indole-1,4-dione | Human Necessities | 19 | Expired |
| US8450527B2 | Amine derivative compounds for treating ophthalmic diseases and disorders | Chemistry; Metallurgy | 17 | Active |
| US5401880A | Chemical prevention or reversal of cataract by phase separation inhibitors | Chemistry; Metallurgy | 15 | Expired |
| US6008208A | Compositions and methods for treating bone deficit conditions | Human Necessities | 14 | Expired |
| US7022856B2 | Carboline derivatives | Human Necessities | 12 | Expired |
| US7115621B2 | Chemical compounds | Human Necessities | 12 | Expired |
| US6124299A | Calcitonin mimetics | Chemistry; Metallurgy | 12 | Expired |
| US6838456B2 | Condensed pyridoindole derivatives | Human Necessities | 12 | Expired |
| US7122554B2 | Carboline derivatives | Human Necessities | 11 | Expired |
| US6395740B1 | Calcitonin mimetics | Chemistry; Metallurgy | 9 | Expired |
| US6992192B2 | Carboline derivatives as PDE5 inhibitors | Human Necessities | 9 | Expired |
| US6825197B2 | Cyclic GMP-specific phosphodiesterase inhibitors | Chemistry; Metallurgy | 8 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.